CN111955741A - 一种用于体重控制的组合物及其应用 - Google Patents
一种用于体重控制的组合物及其应用 Download PDFInfo
- Publication number
- CN111955741A CN111955741A CN202010809765.5A CN202010809765A CN111955741A CN 111955741 A CN111955741 A CN 111955741A CN 202010809765 A CN202010809765 A CN 202010809765A CN 111955741 A CN111955741 A CN 111955741A
- Authority
- CN
- China
- Prior art keywords
- composition
- weight
- parts
- fructo
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 146
- 238000004260 weight control Methods 0.000 title claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 62
- 239000000835 fiber Substances 0.000 claims abstract description 58
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 37
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 37
- 239000006041 probiotic Substances 0.000 claims abstract description 37
- 235000018291 probiotics Nutrition 0.000 claims abstract description 37
- 241000186012 Bifidobacterium breve Species 0.000 claims abstract description 36
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 33
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 33
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 32
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 32
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 32
- 229940016667 resveratrol Drugs 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 31
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 31
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 31
- 235000021014 blueberries Nutrition 0.000 claims abstract description 31
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 29
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 29
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 29
- 241000209140 Triticum Species 0.000 claims abstract description 29
- 235000021307 Triticum Nutrition 0.000 claims abstract description 29
- 239000011425 bamboo Substances 0.000 claims abstract description 29
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 24
- 244000269722 Thea sinensis Species 0.000 claims abstract 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 45
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 45
- 241001330002 Bambuseae Species 0.000 claims description 28
- 229930006000 Sucrose Natural products 0.000 claims description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 15
- 239000005720 sucrose Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000006188 syrup Substances 0.000 claims description 10
- 235000020357 syrup Nutrition 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 3
- 238000011033 desalting Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000002417 nutraceutical Substances 0.000 claims description 3
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 3
- 210000004911 serous fluid Anatomy 0.000 claims description 2
- 230000037221 weight management Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 abstract description 15
- 241000894006 Bacteria Species 0.000 abstract description 14
- 230000009286 beneficial effect Effects 0.000 abstract description 8
- 230000036186 satiety Effects 0.000 abstract description 4
- 235000019627 satiety Nutrition 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000013325 dietary fiber Nutrition 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 235000012631 food intake Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 30
- 241001122767 Theaceae Species 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 235000009200 high fat diet Nutrition 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 235000021590 normal diet Nutrition 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 230000000529 probiotic effect Effects 0.000 description 13
- 238000002156 mixing Methods 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 241000186000 Bifidobacterium Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 208000031648 Body Weight Changes Diseases 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000004579 body weight change Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 241000193403 Clostridium Species 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 241000606125 Bacteroides Species 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007413 intestinal health Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 102220220001 rs188579132 Human genes 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000013238 high-fat diet model Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K11/00—Fructose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
组别 | 总菌数 | 拟杆菌 | 双歧杆菌 | 乳酸杆菌 | 普拉梭菌 |
正常饮食 | 11.2±0.10 | 10.3±0.10 | 5.79±0.34 | 7.30±0.24 | 9.39±0.32 |
高脂饮食 | 10.6±0.08 | 9.82±0.09 | 5.65±0.20 | 6.67±0.18 | 8.90±0.23 |
实施例1 | 10.8±0.04 | 10.0±0.16 | 6.19±0.21 | 6.93±0.36 | 9.87±0.48 |
实施例2 | 10.6±0.24 | 9.81±0.26 | 6.42±0.41 | 7.40±0.25 | 10.24±0.59 |
实施例3 | 10.8±0.16 | 10.0±0.23 | 6.86±0.28 | 7.59±0.25 | 10.23±0.26 |
实施例4 | 10.9±0.06 | 9.96±0.22 | 6.84±0.28 | 7.36±0.63 | 9.93±0.30 |
实施例5 | 10.6±0.13 | 10.23±0.15 | 6.39±0.2 | 7.39±0.26 | 10.02±0.48 |
对比例1 | 10.7±0.14 | 9.92±0.18 | 6.25±0.31 | 7.21±0.20 | 8.85±0.23 |
对比例2 | 11.0±0.24 | 9.75±0.06 | 6.14±0.46 | 7.43±0.83 | 9.11±0.19 |
对比例3 | 10.6±0.16 | 9.76±0.14 | 6.07±0.23 | 7.22±0.16 | 9.03±0.19 |
对比例4 | 9.7±0.29 | 8.90±0.49 | 5.67±0.33 | 6.31±0.13 | 9.23±0.07 |
组别 | 乳双歧杆菌B420 | 短双歧杆菌B-3 |
低聚果糖-1 | A1 | B1 |
低聚果糖-2 | A2 | B2 |
A1 | A2 | B1 | B2 | |
0月 | 4.3×10<sup>10</sup> | 4.5×10<sup>10</sup> | 2.6×10<sup>10</sup> | 2.58×10<sup>10</sup> |
3月 | 4.2×10<sup>10</sup> | 4.2×10<sup>10</sup> | 1.9×10<sup>10</sup> | 1.41×10<sup>10</sup> |
6月 | 3.7×10<sup>10</sup> | 2.4×10<sup>10</sup> | 1.8×10<sup>10</sup> | 1.44×10<sup>10</sup> |
9月 | 3.8×10<sup>10</sup> | 2.2×10<sup>10</sup> | 1.48×10<sup>10</sup> | 1.57×10<sup>10</sup> |
12月 | 2.9×10<sup>10</sup> | 1.9×10<sup>10</sup> | 1.31×10<sup>10</sup> | 1.32×10<sup>10</sup> |
15月 | 1.9×10<sup>10</sup> | 9.55×10<sup>9</sup> | 1.06×10<sup>10</sup> | 9.4×10<sup>9</sup> |
18月 | 1.99×10<sup>10</sup> | 2.2×10<sup>9</sup> | 9.9×10<sup>9</sup> | 8.5×10<sup>9</sup> |
A1 | A2 | B1 | B2 | |
0月 | 10.63 | 10.65 | 10.41 | 10.41 |
3月 | 10.62 | 10.62 | 10.28 | 10.15 |
6月 | 10.57 | 10.38 | 10.26 | 10.16 |
9月 | 10.58 | 10.34 | 10.17 | 10.20 |
12月 | 10.46 | 10.28 | 10.12 | 10.12 |
15月 | 10.28 | 9.98 | 10.03 | 9.97 |
18月 | 10.3 | 9.34 | 10.00 | 9.93 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010809765.5A CN111955741B (zh) | 2020-08-12 | 2020-08-12 | 一种用于体重控制的组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010809765.5A CN111955741B (zh) | 2020-08-12 | 2020-08-12 | 一种用于体重控制的组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111955741A true CN111955741A (zh) | 2020-11-20 |
CN111955741B CN111955741B (zh) | 2022-11-11 |
Family
ID=73364331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010809765.5A Active CN111955741B (zh) | 2020-08-12 | 2020-08-12 | 一种用于体重控制的组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111955741B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113750172A (zh) * | 2021-09-01 | 2021-12-07 | 西安诺众康健生物科技有限责任公司 | 一种减重组合物及其在制备减肥产品中的应用 |
CN116019223A (zh) * | 2022-12-07 | 2023-04-28 | 山东奥博森生物药业股份有限公司 | 一种益生菌组合物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104824662A (zh) * | 2015-04-10 | 2015-08-12 | 圣原健康产业有限公司 | 具调节肠道菌群功能的乳酸菌组合物及其制备方法与应用 |
CN106617091A (zh) * | 2016-11-08 | 2017-05-10 | 广东正当年生物科技有限公司 | 一种益生菌和益生元复合制剂 |
CA3020389A1 (en) * | 2016-04-14 | 2017-10-19 | Dupont Nutrition Biosciences Aps | Bifidobacteria for increasing lean body mass |
CN111254089A (zh) * | 2019-12-30 | 2020-06-09 | 杭州娃哈哈科技有限公司 | 一株具有减肥功能的植物乳杆菌及其应用 |
CN111374256A (zh) * | 2018-12-29 | 2020-07-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | 益生菌组合物及其用途、食品和药品 |
-
2020
- 2020-08-12 CN CN202010809765.5A patent/CN111955741B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104824662A (zh) * | 2015-04-10 | 2015-08-12 | 圣原健康产业有限公司 | 具调节肠道菌群功能的乳酸菌组合物及其制备方法与应用 |
CA3020389A1 (en) * | 2016-04-14 | 2017-10-19 | Dupont Nutrition Biosciences Aps | Bifidobacteria for increasing lean body mass |
CN106617091A (zh) * | 2016-11-08 | 2017-05-10 | 广东正当年生物科技有限公司 | 一种益生菌和益生元复合制剂 |
CN111374256A (zh) * | 2018-12-29 | 2020-07-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | 益生菌组合物及其用途、食品和药品 |
CN111254089A (zh) * | 2019-12-30 | 2020-06-09 | 杭州娃哈哈科技有限公司 | 一株具有减肥功能的植物乳杆菌及其应用 |
Non-Patent Citations (2)
Title |
---|
陈亚非等: "低聚果糖与小麦纤维――复合膳食纤维调节肠道菌群作用的研究", 《食品工业科技》 * |
陈坚等: "《小细菌大健康 现代社会慢病微生态健康管理》", 30 November 2017, 复旦大学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113750172A (zh) * | 2021-09-01 | 2021-12-07 | 西安诺众康健生物科技有限责任公司 | 一种减重组合物及其在制备减肥产品中的应用 |
CN113750172B (zh) * | 2021-09-01 | 2022-06-28 | 西安诺众康健生物科技有限责任公司 | 一种减重组合物及其在制备减肥产品中的应用 |
CN116019223A (zh) * | 2022-12-07 | 2023-04-28 | 山东奥博森生物药业股份有限公司 | 一种益生菌组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN111955741B (zh) | 2022-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Markowiak et al. | Effects of probiotics, prebiotics, and synbiotics on human health | |
Mohan et al. | Effect of honey in improving the gut microbial balance | |
Guarner et al. | World gastroenterology organisation global guidelines: probiotics and prebiotics october 2011 | |
Boehm et al. | Prebiotic concept for infant nutrition | |
US7981412B2 (en) | Food containing a probiotic and an isolated β-glucan and methods of use thereof | |
WO2019112054A1 (ja) | 新規ビフィドバクテリウム属細菌及び当該細菌を含む組成物 | |
WO2007140622A1 (en) | Dairy-derived probiotic compositions and uses thereof | |
WO2007140621A1 (en) | Probiotic compositions and uses thereof | |
Majeed et al. | Cranberry seed fibre: a promising prebiotic fibre and its fermentation by the probiotic Bacillus coagulans MTCC 5856 | |
CN112056399A (zh) | 一种增强免疫力的益生菌组合物及其应用 | |
JP2012519659A (ja) | 共生メープルの生成組成物および方法 | |
CN111955741B (zh) | 一种用于体重控制的组合物及其应用 | |
CN108850397A (zh) | 一种止腹泻的益生菌凝胶糖果及其制备方法 | |
Saville et al. | Xylooligosaccharidesand arabinoxylanoligosaccharides and their application as prebiotics | |
CN114921363A (zh) | 一种抑制脂肪积累的复合益生菌及其应用 | |
Ozcan et al. | Effect of stevia and inulin interactions on fermentation profile and short‐chain fatty acid production of Lactobacillus acidophilus in milk and in vitro systems | |
CN112970990A (zh) | 一种具有减肥降脂作用的益生菌固体饮料及其制备工艺 | |
CN111955740A (zh) | 一种用于缓解和治疗特应性皮炎的组合物及其应用 | |
CN112616932A (zh) | 保护口腔健康的羊奶片及其制备方法 | |
CN105995443B (zh) | 一种婴幼儿益肠营养米粉及其制备方法 | |
Kumar et al. | Potato probiotics for human health | |
Ahmed et al. | Hypocholesterolaemic effect of probiotic yogurt enriched with barley β-glucan in rats fed on a high-cholesterol diet | |
Demirci et al. | Immature wheat grain as a potential prebiotic ingredient in set-type yoghurts: impact on antioxidative, textural properties and survival of different probiotics | |
KR101709246B1 (ko) | 다시마 및 복합 유산균을 이용한 항비만용 신바이오틱스 조성물 | |
CN116891810A (zh) | 具有降血糖功效的益生菌组合物、益生菌益生元复合制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 529040 No.133, Gaoxin West Road, Gaoxin District, Jiangmen City, Guangdong Province Applicant after: Smart Pharmaceutical Technology Co.,Ltd. Address before: 529040 No.133, Gaoxin West Road, Gaoxin District, Jiangmen City, Guangdong Province Applicant before: QUANTUM HI-TECH(CHINA) BIOLOGICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220613 Address after: 529040 No. 133, Gaoxin West Road, Gaoxin District, Jiangmen City, Guangdong Province (one address with multiple photos) Applicant after: Quantum hi tech (Guangdong) biology Co.,Ltd. Address before: 529040 No.133, Gaoxin West Road, Gaoxin District, Jiangmen City, Guangdong Province Applicant before: Smart Pharmaceutical Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |